| Product Code: ETC5261514 | Publication Date: Nov 2023 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
Fiji`s corticosteroid import market in 2024 continued to be dominated by key suppliers including New Zealand, Australia, India, UK, and Pakistan, reflecting a high Herfindahl-Hirschman Index (HHI) concentration. The market demonstrated strong growth with a compound annual growth rate (CAGR) of 25.68% from 2020 to 2024. Despite a slight slowdown in the growth rate from 2023 to 2024 at 0.17%, the sustained upward trend indicates a promising outlook for the corticosteroid import market in Fiji.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Fiji Corticosteroid Market Overview |
3.1 Fiji Country Macro Economic Indicators |
3.2 Fiji Corticosteroid Market Revenues & Volume, 2021 & 2031F |
3.3 Fiji Corticosteroid Market - Industry Life Cycle |
3.4 Fiji Corticosteroid Market - Porter's Five Forces |
3.5 Fiji Corticosteroid Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Fiji Corticosteroid Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.7 Fiji Corticosteroid Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Fiji Corticosteroid Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic inflammatory disorders in Fiji |
4.2.2 Growing awareness and acceptance of corticosteroid treatments among healthcare professionals and patients |
4.2.3 Government initiatives to improve healthcare infrastructure and access to medications in Fiji |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines for the use of corticosteroids in Fiji |
4.3.2 Competition from alternative treatment options such as non-steroidal anti-inflammatory drugs (NSAIDs) |
4.3.3 Limited availability of specialized healthcare professionals for prescribing corticosteroids |
5 Fiji Corticosteroid Market Trends |
6 Fiji Corticosteroid Market Segmentations |
6.1 Fiji Corticosteroid Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Fiji Corticosteroid Market Revenues & Volume, By Glucocorticoids, 2021-2031F |
6.1.3 Fiji Corticosteroid Market Revenues & Volume, By Mineralocorticoids, 2021-2031F |
6.2 Fiji Corticosteroid Market, By Administration |
6.2.1 Overview and Analysis |
6.2.2 Fiji Corticosteroid Market Revenues & Volume, By Topical Steroids, 2021-2031F |
6.2.3 Fiji Corticosteroid Market Revenues & Volume, By Inhaled Steroids, 2021-2031F |
6.2.4 Fiji Corticosteroid Market Revenues & Volume, By Oral Forms, 2021-2031F |
6.2.5 Fiji Corticosteroid Market Revenues & Volume, By Systemic Forms, 2021-2031F |
6.2.6 Fiji Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
6.3 Fiji Corticosteroid Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Fiji Corticosteroid Market Revenues & Volume, By Rheumatology Indications, 2021-2031F |
6.3.3 Fiji Corticosteroid Market Revenues & Volume, By Skin Allergies, 2021-2031F |
6.3.4 Fiji Corticosteroid Market Revenues & Volume, By Endocrinology, 2021-2031F |
6.3.5 Fiji Corticosteroid Market Revenues & Volume, By Gastroenterology, 2021-2031F |
6.3.6 Fiji Corticosteroid Market Revenues & Volume, By Acute Respiratory Diseases, 2021-2031F |
6.3.7 Fiji Corticosteroid Market Revenues & Volume, By Others, 2021-2031F |
7 Fiji Corticosteroid Market Import-Export Trade Statistics |
7.1 Fiji Corticosteroid Market Export to Major Countries |
7.2 Fiji Corticosteroid Market Imports from Major Countries |
8 Fiji Corticosteroid Market Key Performance Indicators |
8.1 Number of prescriptions for corticosteroids in Fiji |
8.2 Patient adherence rate to corticosteroid treatment regimens |
8.3 Number of healthcare facilities offering corticosteroid treatments |
8.4 Patient satisfaction with corticosteroid therapy |
8.5 Rate of adverse events reported related to corticosteroid use |
9 Fiji Corticosteroid Market - Opportunity Assessment |
9.1 Fiji Corticosteroid Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Fiji Corticosteroid Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.3 Fiji Corticosteroid Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Fiji Corticosteroid Market - Competitive Landscape |
10.1 Fiji Corticosteroid Market Revenue Share, By Companies, 2024 |
10.2 Fiji Corticosteroid Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here